- Home
- ISPR vs FBRX Comparison
ISPR vs FBRX Comparison
Compare ISPR & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- FBRX
- Stock Information
- Founded
- ISPR 2010
- FBRX N/A
- Country
- ISPR United States
- FBRX United States
- Employees
- ISPR N/A
- FBRX N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ISPR Health Care
- FBRX Health Care
- Exchange
- ISPR Nasdaq
- FBRX Nasdaq
- Market Cap
- ISPR 152.0M
- FBRX 154.5M
- IPO Year
- ISPR 2023
- FBRX N/A
- Fundamental
- Price
- ISPR $2.44
- FBRX $14.77
- Analyst Decision
- ISPR Strong Buy
- FBRX Strong Buy
- Analyst Count
- ISPR 1
- FBRX 3
- Target Price
- ISPR $7.50
- FBRX $68.00
- AVG Volume (30 Days)
- ISPR 52.5K
- FBRX 102.9K
- Earning Date
- ISPR 11-10-2025
- FBRX 11-13-2025
- Dividend Yield
- ISPR N/A
- FBRX N/A
- EPS Growth
- ISPR N/A
- FBRX N/A
- EPS
- ISPR N/A
- FBRX N/A
- Revenue
- ISPR $127,494,304.00
- FBRX N/A
- Revenue This Year
- ISPR $60.96
- FBRX N/A
- Revenue Next Year
- ISPR $23.96
- FBRX N/A
- P/E Ratio
- ISPR N/A
- FBRX N/A
- Revenue Growth
- ISPR N/A
- FBRX N/A
- 52 Week Low
- ISPR $2.09
- FBRX $4.11
- 52 Week High
- ISPR $7.47
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- ISPR 40.32
- FBRX 56.66
- Support Level
- ISPR $2.27
- FBRX $13.76
- Resistance Level
- ISPR $2.65
- FBRX $15.49
- Average True Range (ATR)
- ISPR 0.20
- FBRX 1.36
- MACD
- ISPR -0.04
- FBRX -0.07
- Stochastic Oscillator
- ISPR 27.46
- FBRX 36.01
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).